Cargando…
Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics
OBJECTIVES: Drugs for targeted therapy have become a new strategy of adjuvant therapy for treatment of lung cancer. The Keap1 (kelch-like ECH-associated protein 1)–Nrf2 (nuclear factor erythroid 2-related factor 2) pathway is recognized to be critical in regulating genes related to the cellular prot...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643752/ https://www.ncbi.nlm.nih.gov/pubmed/29063005 http://dx.doi.org/10.1016/j.cdtm.2015.09.002 |